ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $9.47M invested in Enlivex Therapeutics in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.56M
2
+$2.46M
3
+$1.09M
4
DA
DSC Advisors
Illinois
+$833K
5
SFM
Soros Fund Management
New York
+$518K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.56M
2
$2.46M
3
$1.09M
4
$833K
5
$518K
6
$5K
7
$4K
8
$2K